Silence Therapeutics

Silence Therapeutics is a clinical-stage biotechnology company focused on discovering and developing RNA interference therapeutics using its proprietary siRNA platform. The company’s revenue has historically come from collaboration, licensing, royalty, and milestone arrangements rather than commercial product sales.

Relationship details are part of the Pro plan.